The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrew D Zelenetz Alison J Moskowitz Jacob D Soumerai Mrinal Gounder Paul Hamlin Steven M Horwitz |
| Publication date | March 17, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |